BodyLogicMD

The question every prospective investor must answer before committing capital to a healthcare franchise is deceptively simple: does this brand solve a problem large enough, for a demographic growing fast enough, to sustain a business through the inherent complexity of physician-led care delivery? BodyLogicMD was founded in 2003 in Boca Raton, Florida, by Patrick Savage, who serves as both the company's CEO and its founding visionary. The model Savage built was designed to address one of the most underserved categories in American healthcare — hormonal imbalance, accelerated aging, diminished vitality, and the cascade of metabolic conditions that affect tens of millions of adults, particularly those in the baby boomer generation moving through their fifties, sixties, and beyond. BodyLogicMD operates as a network of physician-owned practices, a structural distinction that separates it from corporate-owned clinic chains and gives each franchise location a credentialed medical authority at its center. Dr. Jennifer Landa serves as Chief Medical Officer, overseeing clinical protocols across the entire BodyLogicMD network. The company has built its reputation around bioidentical hormone replacement therapy, functional medicine, nutrition counseling, fitness guidance, and anti-aging wellness programs that compete not just on treatment efficacy but on the personalized, concierge-style patient experience that traditional primary care has largely abandoned. According to the most recent data available, BodyLogicMD operates in approximately 50 locations across 32 states, serves 17,000 active patients, and employs 70 practitioners — a national footprint that positions it as one of the most established and fastest-growing networks in integrative medicine, with over two decades of operating history. The total addressable market for the Offices of Physicians category — where BodyLogicMD is formally classified — reached $749.5 billion in recorded sales in 2025, with the broader physician services market estimated at $840 billion. This independent analysis is produced to serve investors making high-stakes capital allocation decisions, not to market the franchise on behalf of its franchisor.

The industry landscape in which BodyLogicMD competes is defined by structural tailwinds powerful enough to make even a modestly executed franchise strategy viable over a long time horizon. The U.S. physician groups market was estimated at $349.49 billion in 2024 and is projected to grow at a compound annual growth rate of 7.62 percent from 2025 through 2030, according to current market research. A separate valuation placed the same market at $305.88 billion in 2024, with a projected trajectory to $444.79 billion by 2032 at a CAGR of 4.8 percent. The broader Medical Offices of Physicians and Specialists industry recorded an annual growth rate of 6.8 percent over the past five years, a figure that exceeds the growth rate of most retail or food-service franchise categories by a meaningful margin. Several macro forces are compounding simultaneously: the aging of the baby boomer generation is dramatically increasing demand for the specific services BodyLogicMD delivers — hormonal balance, sexual wellness, weight management, and preventive care — while rising consumer health awareness is driving a generational shift toward proactive, personalized medicine rather than reactive sick-care visits. The prevalence of chronic conditions including diabetes, cardiovascular disease, and metabolic syndrome continues to expand the universe of potential patients who benefit from the functional medicine approach BodyLogicMD practices. Technological advancement in diagnostics, combined with the expansion of telemedicine capabilities, has made it structurally easier for franchise networks to serve patients across wider geographies without proportional increases in fixed overhead. BodyLogicMD's inclusion of telemedicine and home-testing options in its service menu positions the brand directly in front of this shift. The physician services industry remains relatively fragmented at the independent practice level, with a well-documented consolidation trend driven by private equity acquisition of small practices — a dynamic that paradoxically creates opportunity for organized franchise networks to offer solo practitioners a credible alternative to hospital acquisition or private equity buyout. BodyLogicMD is recognized as one of the most established and fastest-growing networks in integrative medicine, a category that sits at the intersection of several of these converging secular trends.

The BodyLogicMD franchise investment requires a meaningful but not prohibitive capital commitment that places it in the accessible-to-mid-tier range of healthcare franchise opportunities. The initial franchise fee ranges from $50,000 to $70,000, with the specific fee amount indexed to market size — a $50,000 fee applies to smaller markets, while fees of $66,000 and $70,000 correspond to markets with larger populations of potential patients. This tiered fee structure is notable because it directly ties the upfront cost to the revenue opportunity embedded in the territory, a franchise design choice that aligns franchisor and franchisee incentives from day one. Total initial investment to open a BodyLogicMD franchise is estimated between $85,100 and $182,650, with a closely corroborating estimate placing the range at $80,800 to $183,000. The spread between the low and high ends of this range is driven by geography, local real estate costs, market size, and the degree of build-out required versus a conversion of an existing medical practice space. Working capital requirements are estimated at $25,000 to $75,000, with a noted minimum cash requirement of $20,000 — this working capital is explicitly designed to cover three months of operating expenses including employee salaries, taxes, insurance premiums, rent, utilities, telephony, business internet, technology support, and routine day-to-day expenses. The franchise fee and total investment structure are inclusive of training and territory fees, meaning the headline investment figures represent a relatively complete picture of upfront costs rather than a base number subject to significant upward revision. For context, the professional services franchising category typically carries royalty fees in the 8 to 12 percent range based on industry benchmarks, and marketing or advertising fees in comparable health and fitness franchise categories run approximately 4 percent of gross revenue. The all-in total investment ceiling of approximately $183,000 is substantially lower than most healthcare clinic franchise concepts that require dedicated medical buildouts, imaging equipment, or pharmacy integrations — a structural affordability advantage that makes the BodyLogicMD franchise cost accessible to a broader pool of qualified physician candidates and physician-partnered investors.

The daily operating model of a BodyLogicMD franchise is built around a physician-led, patient-centric care delivery structure that requires a qualified medical practitioner at its core. Franchisees engage patients through a combination of in-office consultation days and telemedicine visits, with the flexibility of virtual care delivery allowing the practice to serve patients across state lines in the 30 states where BodyLogicMD's network operates through telemedicine. The staffing model is lean relative to traditional medical practices — each franchise location is assigned a dedicated Sales Executive, a Concierge Service Representative, and a Business Optimization Agent provided through corporate support infrastructure, which meaningfully reduces the administrative hiring burden on the franchisee at launch. The initial training program runs approximately two weeks and is conducted at corporate headquarters in Boca Raton, Florida, covering clinical protocols, business operations, technology platforms, and patient acquisition systems. The four-step onboarding process moves sequentially through a program demonstration, agreement signing, onboarding training completion, and enrollment in monthly clinical and financial reviews — a structured cadence that provides franchisees with both initial competency and ongoing accountability. Territory structure is tied directly to the initial franchise fee paid, with larger market territories commanding the $66,000 to $70,000 fee tier, giving franchisees clear visibility into what geographic scope they are purchasing. Ongoing support includes computer and technology platforms, business development resources, and the continued involvement of the three dedicated support roles assigned at launch. The monthly clinical and financial review cadence is a distinctive structural element that keeps franchisee performance visible to corporate on a regular basis, enabling early intervention when a location underperforms relative to benchmarks.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document in a form that provides specific average revenue per unit, median revenue, or profit margin figures. The FDD does confirm that BodyLogicMD makes financial performance representations in Item 19, and that "revenue" in that context means total revenue realized from operation of the franchise — but the disclosure explicitly states that net profit information is excluded because it varies significantly from franchisee to franchisee depending on factors including the number of patient consultation days per week, hours scheduled for visits, and the franchisee's pricing decisions for consultations. The FDD also notes that expense and cost information is not included in the Item 19 disclosure, which limits the ability to construct a fully modeled unit economics picture from the FDD alone. That said, the available operational data provides meaningful context: the network serves 17,000 active patients across approximately 50 locations, implying an average active patient count of roughly 340 patients per location. The physician groups and functional medicine segment in which BodyLogicMD operates benchmarks revenue per patient visit in the range typical for integrative and concierge-style medicine practices, which generally command premium pricing relative to standard primary care due to the personalized, time-intensive nature of consultation and ongoing treatment monitoring. The company's recognition as a Top 10 Hormone Provider of 2023 signals competitive market validation. Investors should request the full Item 19 disclosure from BodyLogicMD directly and conduct detailed financial modeling based on the specific market, patient volume assumptions, and pricing strategy applicable to their target territory before committing capital.

BodyLogicMD's growth trajectory reflects an organization that has moved from a regional concept to a nationally recognized integrative medicine franchise network over two decades of operation. The 2020 Franchise Disclosure Document reported 47 franchised locations operating in 29 states, with the West region representing the densest concentration of units at 15 locations — a data point that suggests either a coastal market strategy or organic physician interest clustering in that region. More recent CEO-level data indicates the network has reached 50 locations across 32 states with 70 practitioners, demonstrating measurable geographic expansion since the 2020 FDD baseline. The BodyLogicMD website's current "About Us" language describes approximately 40 affiliated practitioners in 24 franchise practice locations serving 30 states through a combination of in-office and telemedicine visits, reflecting the network's hybrid service delivery model. The competitive moat BodyLogicMD has constructed rests on several structural pillars: 17-plus years of brand equity in a category — bioidentical hormone replacement therapy and functional medicine — that has seen dramatically increased consumer awareness and acceptance over that period; a physician-owned practice model that lends clinical credibility that purely commercial wellness brands cannot easily replicate; and a telemedicine-integrated service delivery system that expands the effective patient catchment area beyond what physical office locations alone could reach. The company's recognition as a Top 10 Hormone Provider of 2023 provides third-party validation of its clinical positioning. CEO Patrick Savage has made explicit expansion plans a stated corporate priority, with the company actively seeking to expand into new markets and offering partnerships to clinics looking to broaden their service offerings — a dual-channel growth strategy that combines traditional franchise development with clinical partnership agreements. The broader consolidation trend in physician services, in which solo practitioners face pressure from hospital acquisition and private equity aggregation, creates a fertile environment for a franchise model that offers independence with infrastructure.

The ideal BodyLogicMD franchisee candidate is, by the nature of the model, either a licensed physician or a physician-partnered investor who can recruit and credential a qualified medical practitioner to serve as the clinical anchor of the practice. The physician-owned structure is not incidental — it is foundational to the brand's clinical credibility and regulatory compliance framework. Candidates with backgrounds in internal medicine, family practice, endocrinology, or integrative medicine are structurally well-positioned to leverage the BodyLogicMD platform without requiring extensive clinical reorientation. The franchise agreement's territory structure means that market selection at the time of investment directly determines the size of the addressable patient population and the corresponding fee paid — a prospective franchisee targeting a major metropolitan market should anticipate the $70,000 franchise fee tier and total investments in the upper range of the $80,800 to $183,000 investment window. The telemedicine component of the operating model allows franchisees in geographically smaller markets to extend patient reach across state lines, partially mitigating the patient volume limitations of smaller physical territories. Available territories span the United States, with 32 states already represented in the network and the company actively seeking expansion into underserved markets. Monthly clinical and financial reviews create an ongoing accountability structure, and the four-step onboarding process from agreement signing to operational launch is designed to move new franchisees into patient-generating activity efficiently. Multi-unit development is a potential pathway for physicians or medical practice groups seeking to deploy capital across multiple markets under the BodyLogicMD system.

BodyLogicMD represents an investment thesis that merits rigorous, structured due diligence from any investor seriously evaluating the convergence of healthcare franchise growth, aging demographics, and integrative medicine demand. The brand operates at the intersection of a $749.5 billion physician services market growing at 6.8 percent annually and a specific functional medicine niche where consumer adoption is accelerating as baby boomers seek solutions beyond what conventional medicine offers for hormonal, metabolic, and longevity-related conditions. The BodyLogicMD franchise opportunity carries a PeerSense FPI Score of 45, classified as Fair, which signals that investors should conduct thorough independent financial analysis before committing — particularly given the absence of disclosed net profit data in the current FDD and the mixed employee feedback in publicly available reviews. The total investment range of $80,800 to $183,000 with a franchise fee between $50,000 and $70,000 is competitive for a healthcare franchise in a high-growth category, but franchise investment decisions of this magnitude require more than marketing materials and a compelling market narrative. PeerSense provides exclusive due diligence data including SBA lending history, FPI score analysis, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to evaluate BodyLogicMD against comparable franchise opportunities across the physician services and healthcare wellness categories. The combination of a 20-year operating history, a 50-location national network serving 17,000 active patients, Top 10 Hormone Provider recognition in 2023, and a $840 billion total addressable market creates a foundation for a serious investment conversation — but the right conversation starts with complete data. Explore the complete BodyLogicMD franchise profile on PeerSense to access the full suite of independent franchise intelligence data.